Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 445

1.

Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.

Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL.

Clin Pharmacol Ther. 2009 Oct;86(4):425-9. doi: 10.1038/clpt.2009.95. Epub 2009 Jul 8.

PMID:
19587643
[PubMed - indexed for MEDLINE]
2.

Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.

Hines LE, Ceron-Cabrera D, Romero K, Anthony M, Woosley RL, Armstrong EP, Malone DC.

Clin Ther. 2011 Jan;33(1):36-45. doi: 10.1016/j.clinthera.2011.01.021.

PMID:
21397772
[PubMed - indexed for MEDLINE]
3.

Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.

Martins MA, Carlos PP, Ribeiro DD, Nobre VA, C├ęsar CC, Rocha MO, Ribeiro AL.

Eur J Clin Pharmacol. 2011 Dec;67(12):1301-8. doi: 10.1007/s00228-011-1086-4. Epub 2011 Jun 24.

PMID:
21701882
[PubMed - indexed for MEDLINE]
4.

Concordance of severity ratings provided in four drug interaction compendia.

Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, Lipton RB.

J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):136-41.

PMID:
15098847
[PubMed - indexed for MEDLINE]
5.

Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.

Olvey EL, Clauschee S, Malone DC.

Clin Pharmacol Ther. 2010 Jan;87(1):48-51. doi: 10.1038/clpt.2009.198. Epub 2009 Nov 4. Erratum in: Clin Pharmacol Ther. 2010 Jul;88(1):138.

PMID:
19890252
[PubMed - indexed for MEDLINE]
6.

Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.

Wong CM, Ko Y, Chan A.

Ann Pharmacother. 2008 Dec;42(12):1737-48. doi: 10.1345/aph.1L255. Epub 2008 Nov 25. Review.

PMID:
19033481
[PubMed - indexed for MEDLINE]
7.

Comparative assessment of four drug interaction compendia.

Vitry AI.

Br J Clin Pharmacol. 2007 Jun;63(6):709-14. Epub 2006 Dec 7.

PMID:
17166171
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.

Chao SD, Maibach HI.

Am J Clin Dermatol. 2005;6(2):105-11.

PMID:
15799682
[PubMed - indexed for MEDLINE]
9.

Dietary supplements, herbs and oral anticoagulants: the nature of the evidence.

Wittkowsky AK.

J Thromb Thrombolysis. 2008 Feb;25(1):72-7. Epub 2007 Sep 29. Review.

PMID:
17906915
[PubMed - indexed for MEDLINE]
10.

Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.

Nutescu E, Chuatrisorn I, Hellenbart E.

J Thromb Thrombolysis. 2011 Apr;31(3):326-43. doi: 10.1007/s11239-011-0561-1. Review.

PMID:
21359645
[PubMed - indexed for MEDLINE]
11.

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.

Wysowski DK, Nourjah P, Swartz L.

Arch Intern Med. 2007 Jul 9;167(13):1414-9.

PMID:
17620536
[PubMed - indexed for MEDLINE]
12.

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ.

Pharmacotherapy. 2008 Aug;28(8):992-8. doi: 10.1592/phco.28.8.992.

PMID:
18657016
[PubMed - indexed for MEDLINE]
13.

Systematic overview of warfarin and its drug and food interactions.

Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS.

Arch Intern Med. 2005 May 23;165(10):1095-106. Review.

PMID:
15911722
[PubMed - indexed for MEDLINE]
14.

Warfarin and its interactions with foods, herbs and other dietary supplements.

Nutescu EA, Shapiro NL, Ibrahim S, West P.

Expert Opin Drug Saf. 2006 May;5(3):433-51. Review.

PMID:
16610971
[PubMed - indexed for MEDLINE]
15.

Clinically relevant safety issues associated with St. John's wort product labels.

Clauson KA, Santamarina ML, Rutledge JC.

BMC Complement Altern Med. 2008 Jul 17;8:42. doi: 10.1186/1472-6882-8-42.

PMID:
18637192
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.

Wang LM, Wong M, Lightwood JM, Cheng CM.

Ann Pharmacother. 2010 Jan;44(1):28-34. doi: 10.1345/aph.1M475. Epub 2009 Dec 29.

PMID:
20040698
[PubMed - indexed for MEDLINE]
17.

Interactions of warfarin with drugs and food.

Wells PS, Holbrook AM, Crowther NR, Hirsh J.

Ann Intern Med. 1994 Nov 1;121(9):676-83. Review.

PMID:
7944078
[PubMed - indexed for MEDLINE]
18.

Antineoplastic agents: comparing off-label uses among authoritative drug compendia.

Thompson DF, Keefe CC.

Hosp Formul. 1993 Jul;28(7):641-2, 647.

PMID:
10127046
[PubMed - indexed for MEDLINE]
19.

Rules set for dissemination of off-label-use information.

Miller JL.

Am J Health Syst Pharm. 1999 Feb 1;56(3):204. No abstract available.

PMID:
10030500
[PubMed - indexed for MEDLINE]
20.

Stoning a dead bird: advertising limits on approved new drugs.

Strobos J.

Food Drug Law J. 1995;50(4):533-51. No abstract available.

PMID:
10343018
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk